PRECISION BIOSCIENCES INC
A clinical-stage company using ARCUS gene editing to treat cancer and rare genetic diseases.
DTIL | NDAQ
Overview
Corporate Details
- ISIN(s):
- US74019P2074
- LEI:
- Country:
- United States of America
- Address:
- 302 EAST PETTIGREW STREET, 27701 DURHAM
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Precision BioSciences, Inc. is a clinical-stage gene editing company developing therapies for intractable diseases. The company leverages its proprietary genome editing platform, ARCUS, which employs sequence-specific DNA-cutting enzymes (nucleases) to precisely insert, remove, or repair DNA within living cells and tissues. Precision's therapeutic pipeline focuses on developing both in vivo and ex vivo gene editing treatments for rare genetic diseases, cancer, and infectious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PRECISION BIOSCIENCES INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PRECISION BIOSCIENCES INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PRECISION BIOSCIENCES INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
